MiRNAs-based stem cell therapy for Myocardial disorders: MiRNA-106b-5p enhances Mesenchymal stem cell therapy for Myocardial infarction via suppression of its target gene, 29/July/2014, 04.51 am

MiRNAs-based stem cell therapy for Myocardial disorders: MiRNA-106b-5p enhances Mesenchymal stem cell therapy for Myocardial infarction via suppression of its target gene, 29/July/2014, 04.51 am

MiRNAs-based stem cell therapy for Myocardial disorders: MiRNA-106b-5p enhances Mesenchymal stem cell therapy for Myocardial infarction via suppression of its target gene, 29/July/2014, 04.51 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, MiRNAs-based stem cell therapy for Myocardial disorders: MiRNA-106b-5p enhances Mesenchymal stem  cell therapy for Myocardial infarction via suppression of  its target gene, 29/July/2014, 04.51 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

 * Research cooperation